Growth Opportunities for Digital Biomarkers in Drug Development – Focus on Neurology, Oncology, and Cardiology – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities for Digital Biomarkers in Drug Development” report has been added to ResearchAndMarkets.com’s offering. The study focuses on 3 major therapy areas, neurology, oncology, and cardiology, which digital biomarkers impact. Pharmaceutical companies spend billions of dollars in drug development because of expensive and time-consuming clinical trials, with a meager success rate. Frequent … [Read more…]
